Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
8.43
-0.16 (-1.86%)
Mar 28, 2025, 4:00 PM EDT - Market closed
Amicus Therapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$17.00
Upside
+101.66%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wells Fargo | Wells Fargo | Buy Maintains $18 → $17 | Buy | Maintains | $18 → $17 | +101.66% | Feb 20, 2025 |
Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 20, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $21 | Buy | Reiterates | $21 | +149.11% | Jan 15, 2025 |
Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 13, 2025 |
Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $17 → $12 | Buy → Hold | Downgrades | $17 → $12 | +42.35% | Dec 13, 2024 |
JP Morgan | JP Morgan | Buy Maintains $16 → $17 | Buy | Maintains | $16 → $17 | +101.66% | Nov 12, 2024 |
UBS | UBS | Strong Buy Maintains $19 → $21 | Strong Buy | Maintains | $19 → $21 | +149.11% | Nov 7, 2024 |
Guggenheim | Guggenheim | Strong Buy Maintains $13 → $15 | Strong Buy | Maintains | $13 → $15 | +77.94% | Nov 7, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $20 → $21 | Buy | Maintains | $20 → $21 | +149.11% | Nov 7, 2024 |
Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 7, 2024 |
B of A Securities | B of A Securities | Strong Buy Maintains $13 → $15 | Strong Buy | Maintains | $13 → $15 | +77.94% | Oct 17, 2024 |
Morgan Stanley | Morgan Stanley | Buy Maintains $19 → $18 | Buy | Maintains | $19 → $18 | +113.52% | Oct 11, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $20 | Buy | Reiterates | $20 | +137.25% | Sep 20, 2024 |
Jefferies | Jefferies | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +113.52% | Sep 6, 2024 |
JP Morgan | JP Morgan | Buy Maintains $17 → $16 | Buy | Maintains | $17 → $16 | +89.80% | Aug 16, 2024 |
Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 9, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.